“Dr. Daniel Kraft sat down with Dr. Patrick Hines, founder and CEO at Functional Fluidics, one of the nation’s leading sickle cell disease researchers at Wayne State University in Detroit, where he set up a transformational study to further define biomarkers and other measurable attributes of red blood cells – membrane stability, abnormalities, stickiness and more. In this podcast, Dr. Hines provides a comprehensive list of treatments now in testing, particularly proactive treatments like monoclonal antibodies, hemoglobin modification and oxidative stress reducers.”
